跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IDELVION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IDELVION
Authorized
STANDARD
IDELVION
csl behring canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
635af1f4afc0da85
Company
csl behring canada inc
Type
Standard
Approval Details
Approval Id
635af1f4afc0da85
Drug Approval Canada Name
IDELVION
Product Name
IDELVION
Status
Dormant
Status Date
2023-07-13
Original Market Date
2019-07-04
Din
02451352
Drug Class
Human
Dosage Form
Powder For Solution , Kit
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BD04 COAGULATION FACTOR IX
Atc Name
b 02 bd 04
Aig Number
0157770003
Company Name
csl behring canada inc
Company Address
350, 55 Metcalfe Street, Ottawa, Ontario, Canada, K1P 6L5
Active Ingredients
COAGULATION FACTOR IX (RECOMBINANT), ALBUMIN FUSION PROTEIN (RIX-FP)
1000 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
635af1f4afc0da85
Type
Standard
Back to Health Canada Approvals